ory of Functional Proteomics of Guangdong Province. "There might be some ways of controlling the release of Mig, such as specific inhibitors that interfere [with] the signaling pathways involved," Dr. Jiang said. "Other approaches, such as neutralizing antibodies [and] specific binding peptides, could be tried to block brain damage induced by Mig."
Four to five percent of SARS patients treated at the Guangzhou Institute of Respiratory Diseases experienced central nervous system symptoms, said Dr. Xu; therefore, physicians need to be aware of the potential for brain infection when evaluating patients with the disease. Immunosuppressive drugs should be administered carefully and on an individual basis, as they may allow amplification of the SARS coronavirus in the brain. "Superinfection" with other pathogens could also contribute to SARS' harmful effects on the brain. "Physicians should pay more attention to the prevention of brain damage if [SARS patients] are superinfected with other conditional pathogens," according to Dr. Xu and Dr. Jiang.
'"/>Source:
Infectious Diseases Society of America
Page: 1 2 Related biology news :1.
Bioartificial kidney under study at MCG2.
W.M. Keck Foundation funds study of friendly microbes3.
Yellowstone microbes fueled by hydrogen, according to U. of Colorado study4.
Genome-wide mouse study yields link to human leukemia5.
Clam embryo study shows pollutant mixture adversely affects nerve cell development6.
New imaging method gives early indication if brain cancer therapy is effective, U-M study shows7.
Same mutation aided evolution in many fish species, Stanford study finds8.
Sequencing of marine bacterium will help study of cell communication9.
Genetically modified rice in China benefits farmers health, study finds10.
A new study examines how shared pathogens affect host populations11.
NYU study reveals how brains immune system fights viral encephalitis